We are live on ! Find out more
ALT icon

Altimmune
ALT

36 hedge funds and large institutions have $28.3M invested in Altimmune in 2014 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 12 increasing their positions, 9 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

221% more call options, than puts

Call options by funds: $151K | Put options by funds: $47K

33% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 9

8% less funds holding

Funds holding: 39 → 36 (-3)

22% less capital invested

Capital invested by funds: $36.2M → $28.3M (-$7.9M)

60% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 5

67% less funds holding in top 10

Funds holding in top 10: 3 → 1 (-2)

Holders
36
Holders Change
-3
Holders Change %
-7.69%
% of All Funds
1.03%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.03%
New
2
Increased
12
Reduced
9
Closed
5
Calls
$151K
Puts
$47K
Net Calls
+$104K
Net Calls Change
-$166K

Top Buyers

1
JCI
Jet Capital Investors
New York
+$618K
2
PCM
Potomac Capital Management
New York
+$151K
3
Morgan Stanley
Morgan Stanley
New York
+$86.3K
4
PCM
Perkins Capital Management
Minnesota
+$79.1K
5
CCA
Catalyst Capital Advisors
New York
+$44.8K

Top Sellers

1
SC
Sophrosyne Capital
New York
-$335K
2
OAM
Oxford Asset Management
United Kingdom
-$179K
3
BIT
BlackRock Institutional Trust
California
-$98.6K
4
GMCM
Gruber & McBaine Capital Management
California
-$40.7K
5
Citadel Advisors
Citadel Advisors
Florida
-$40.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
BIM
26
BlackRock Investment Management
Delaware
$11K +$11.8K +26 New
Citadel Advisors
27
Citadel Advisors
Florida
$7K -$40.2K -89 -84%
Citigroup
28
Citigroup
New York
$5K -$2.71K -6 -33%
Manulife (Manufacturers Life Insurance)
29
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$4K – – –
Creative Planning
30
Creative Planning
Kansas
$3K – – –
BNP Paribas Financial Markets
31
BNP Paribas Financial Markets
France
$1.3K – – –
Royal Bank of Canada
32
Royal Bank of Canada
Ontario, Canada
$1K – – –
TRCT
33
Tower Research Capital (TRC)
New York
$1K – – –
GC
34
Globeflex Capital
California
$1K +$452 +1 +50%
AIG
35
American International Group
New York
$423 -$452 -1 -50%
Walleye Trading
36
Walleye Trading
New York
$117 +$30.3K +67 +32%
SC
37
Sophrosyne Capital
New York
– -$335K -608 Closed
OAM
38
Oxford Asset Management
United Kingdom
– -$179K -327 Closed
Renaissance Technologies
39
Renaissance Technologies
New York
– -$40K -72 Closed
AllianceBernstein
40
AllianceBernstein
Tennessee
– -$2K -3 Closed
Deutsche Bank
41
Deutsche Bank
Germany
– -$1K -2 Closed
1
2

ALT Hedge Fund Activity: Q2 2014 in Review

36 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Altimmune (ALT) for Q2 2014, worth a combined $28.3M — down 22% from $36.2M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of ALT and 2 opened new positions — a net loss of 3 holders — while 9 trimmed existing stakes and 12 added.

The largest buyer was Jet Capital Investors, adding an estimated $618K. The largest seller was Sophrosyne Capital, exiting entirely with an estimated $335K sold.

  • 36 institutional investors held Altimmune (ALT) as of Q2 2014, down from 39 in Q1 2014.
  • Funds reported $28.3M of Altimmune stock for Q2 2014, down 22% quarter-over-quarter.
  • 2 funds opened new Altimmune positions in Q2 2014 and 5 closed out, a net change of -3 holders.
  • The largest Altimmune buyer in Q2 2014 was Jet Capital Investors, an estimated $618K added.
  • The largest Altimmune seller in Q2 2014 was Sophrosyne Capital, an estimated $335K sold.

Based on aggregated 13F filings for Q2 2014.